05.13.19

FDA Approves Eylea for All Stages of Diabetic Retinopathy

Source: Regeneron

02.07.19

Regeneron Q4 Earnings & Sales Beat on Strong Eylea Sales

Source: Nasdaq

09.13.18

FDA to Review Eylea (Aflibercept) Injection for the Treatment of Diabetic Retinopathy

Source: Regeneron Pharmaceuticals

08.17.18

FDA Approves 12-Week Dosing for Eylea in Wet AMD Patients

Source: Regeneron Pharmaceuticals

08.14.18

Regeneron Faces Delay to FDA Approval of 12-Week Dosing Schedule for Eylea in Wet AMD

Source: FirstWord

05.04.18

US Sales of Eylea in First Quarter Best Estimates

Source: FirstWord

View more stories